Investment bank · New York
Guggenheim Securities
- Deals
- 106
- M&A
- 80
- Equity raisings
- 25
- Latest
- Sep 2026
What they do
Guggenheim Securities is an investment bank and capital markets firm providing advisory, financing, research, and sales and trading services.
- Deal size
- Recorded deals: median US$670m, from US$39.8m to US$40bn
- Network
- Guggenheim Partners
From guggenheimpartners.com: /services
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
106 of 106 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2026 | GCG | Audax Private Equity | Rexel | Acquisition | Financial adviser to Rexel (acquirer) | Announced | – | Industrial Distribution | Solomon Partners (sell-side)J.P. Morgan (sell-side)Kirkland & Ellis (sell-side)Fredrikson & Byron (sell-side)Rothschild & Co (buy-side)Sidley Austin (buy-side) | Rexel acquisition of GCG |
| Sep 2026 | General Datatech | H.I.G. Capital | Softcat | Acquisition | Financial adviser to GDT (target) | Announced | 1,050.0 | IT Services | Kirkland & Ellis (sell-side)Goodwin (buy-side)Moelis & Company (sell-side) | Softcat acquisition of General Datatech |
| Sep 2026 | Personal care division of AccentCare | AccentCare | Addus HomeCare | Asset sale | Financial adviser to AccentCare (seller) | Announced | 275.0 | Healthcare Services | Evercore (buy-side)Bass, Berry & Sims (buy-side)J.P. Morgan (sell-side)Ropes & Gray (sell-side) | Addus HomeCare acquisition of Personal care division of AccentCare |
| Sep 2026 | Consolidated Precision Products | Warburg Pincus | GE Aerospace | Acquisition | Financial adviser to Consolidated Precision Products (target) | Announced | 11,750.0 | Defence & Aerospace+1 | Paul, Weiss (buy-side)Evercore (buy-side)PJT Partners (buy-side)Morgan Stanley (sell-side)Cleary Gottlieb Steen & Hamilton (sell-side) | GE Aerospace acquisition of Consolidated Precision Products |
| Sep 2026 | Kelvion | Apollo Funds | SLB | Acquisition | Financial adviser to Kelvion (target) | Announced | 4,100.0 | Manufacturing+1 | Sidley Austin (sell-side) | SLB acquisition of Kelvion |
| Sep 2026 | Richey May | – | Genstar Capital | Stake | Financial adviser to Richey May (target) | Announced | – | Accounting, legal and consulting | Genstar Capital stake in Richey May | |
| Sep 2026 | Appleby | – | New Mountain Capital | Stake | Financial adviser to Appleby (target) | Announced | – | Accounting, legal and consulting | New Mountain Capital stake in Appleby | |
| Sep 2026 | IMSAR | – | OceanSound Partners | Acquisition | Financial adviser to IMSAR (target) | Announced | – | Defence & Aerospace+1 | OceanSound Partners acquisition of IMSAR | |
| Sep 2026 | FeatureByte | – | ServiceNow | Acquisition | Financial adviser to FeatureByte (target) | Announced | – | AI+1 | ServiceNow acquisition of FeatureByte | |
| Aug 2026 | Amylyx Pharmaceuticals | – | – | Follow-on offering | Bookrunner | Announced | 575.2 | Biotech+1 | Goodwin (issuer)Leerink Partners (lead manager)Morgan Stanley (lead manager)LifeSci Capital (lead manager) | Amylyx Pharmaceuticals equity raising |
| Aug 2026 | Lynk Global | – | – | Merger | Financial adviser to Lynk | Completed | – | Telecom | Cooley | Omnispace and Lynk Global merger |
| Aug 2026 | EPIQ Design Solutions | Veritas Capital | TTM Technologies | Acquisition | Financial adviser to TTM Technologies (acquirer) | Completed | 1,100.0 | Defence & Aerospace+1 | Polsinelli (buy-side)Latham & Watkins (sell-side)Baird (sell-side) | TTM Technologies acquisition of EPIQ Design Solutions |
| Aug 2026 | Katapult Holdings | – | – | Merger | Financial adviser to Katapult Holdings (acquirer) | Completed | – | Consumer Services+2 | Davis Polk (buy-side)J.P. Morgan (sell-side)King & Spalding (sell-side)Morrison & Foerster (sell-side) | The Aaron's Company and Katapult Holdings merger |
| Aug 2026 | ECI | H.I.G. Capital | Wind Point Partners | Acquisition | Financial adviser to ECI (target) | Completed | – | Managed Services+2 | Baird (sell-side)King & Spalding (sell-side) | Wind Point Partners acquisition of ECI |
| Aug 2026 | Maverick Water Group | Crosstimbers Capital Group | Apollo | Acquisition | Financial adviser to Maverick Water Group (target) | Completed | – | Water+1 | Latham & Watkins (sell-side)Vinson & Elkins (buy-side) | Apollo acquisition of Maverick Water Group |
| Aug 2026 | AdaptHealth | – | – | Joint venture | Financial adviser to AdaptHealth | Announced | – | Healthcare Services+1 | Acquisition of AdaptHealth | |
| Aug 2026 | Windy City Representatives | – | Ambient | Acquisition | Financial adviser to Windy City Representatives (target) | Announced | – | Distribution | Ambient acquisition of Windy City Representatives | |
| Aug 2026 | Vetspire | Thrive Pet Healthcare | Battery | Asset sale | Financial adviser to Thrive Pet Healthcare (seller) | Announced | – | Vertical SaaS+1 | Battery acquisition of Vetspire | |
| Aug 2026 | BlossomHill Therapeutics | – | – | IPO | Bookrunner | Listed | 150.0 | Biotech+2 | J.P. Morgan (lead manager)Leerink Partners (lead manager)LifeSci Capital (lead manager)H.C. Wainwright & Co. (lead manager)Cooley (issuer)Latham & Watkins (lead manager) | BlossomHill Therapeutics IPO |
| Aug 2026 | van den Boom & Associates | – | Gridiron Capital | Acquisition | Financial adviser to Gridiron Capital (acquirer) | Announced | – | – | Gridiron Capital acquisition of van den Boom & Associates | |
| Aug 2026 | Latigo Biotherapeutics | – | – | IPO | Underwriter | Listed | 345.6 | Biotech+2 | Goldman Sachs (lead manager)Jefferies (lead manager)Leerink Partners (lead manager)Cooley (issuer)Latham & Watkins (lead manager) | Latigo Biotherapeutics IPO |
| Aug 2026 | Engage fi | Falfurrias Management Partners | Uplift | Acquisition | Financial adviser to Engage fi (target) | Completed | – | IT Services+2 | Kirkland & Ellis (buy-side)William Blair | Uplift acquisition of Engage fi |
| Aug 2026 | Alafair Biosciences | – | Zimmer Biomet | Acquisition | Financial adviser to Alafair Biosciences (target) | Announced | 375.0 | Medtech | Zimmer Biomet acquisition of Alafair Biosciences | |
| Jul 2026 | Caldera Therapeutics | – | – | Placement | Placement agent to the lead managers | Announced | 278.0 | Biotech+1 | Jefferies (lead manager)TD Securities (lead manager)UBS (lead manager)LifeSci Capital (lead manager)Cooley (lead manager) | Caldera Therapeutics placement |
| Jul 2026 | Jersey Mike’s Subs | Blackstone | – | IPO | Bookrunner and joint lead manager | Listed | 1,000.0 | Restaurants+1 | Morgan Stanley (lead manager)Jefferies (lead manager)J.P. Morgan (lead manager)Barclays (lead manager)BofA Securities (lead manager)Goldman Sachs (lead manager)Evercore (lead manager)UBS (lead manager)Baird (lead manager)Wells Fargo Securities (lead manager)William Blair (lead manager)RBC Capital Markets (lead manager)Deutsche Bank (lead manager)Nomura (lead manager)WR Securities (lead manager)Piper Sandler (lead manager)Raymond James (lead manager)Stifel (lead manager)TD Securities (lead manager)BTIG (lead manager)Mizuho Securities (lead manager)Societe Generale (lead manager)Truist Securities (lead manager)Blackstone Securities Partners (lead manager)PJT Partners (lead manager)Rabo Securities (lead manager)Loop Capital Markets (lead manager)Tigress Financial Partners (lead manager)Academy Securities (lead manager)Drexel Hamilton (lead manager)Penserra Securities (lead manager)Roberts & Ryan (lead manager)Telsey Advisory Group (lead manager)Simpson Thacher & Bartlett (issuer)Davis Polk (lead manager) | Jersey Mike’s Subs IPO |
| Jul 2026 | Reformation | – | – | IPO | Underwriter and bookrunner | Announced | 210.9 | Apparel+2 | J.P. Morgan (lead manager)Morgan Stanley (lead manager)Citi (lead manager)RBC Capital Markets (lead manager)Baird (lead manager)William Blair (lead manager)BTIG (lead manager)Telsey Advisory Group (lead manager)Skadden, Arps, Slate, Meagher & Flom (issuer)Latham & Watkins (lead manager) | Reformation IPO |
| Jul 2026 | Forte Biosciences | – | argenx SE | Acquisition | Financial adviser and fairness opinion to Forte Biosciences (target) | Announced | 2,200.0 | Biotech+1 | Goldman Sachs (buy-side)Freshfields (buy-side)Wilson Sonsini Goodrich & Rosati (sell-side)Innisfree M&A (buy-side) | argenx SE acquisition of Forte Biosciences |
| Jul 2026 | Scribe Therapeutics | – | – | IPO | Underwriter and bookrunner | Listed | 128.7 | Biotech+1 | Leerink Partners (lead manager)Goldman Sachs (lead manager)Wells Fargo Securities (lead manager)Fenwick & West (issuer)Latham & Watkins (lead manager) | Scribe Therapeutics IPO |
| Jul 2026 | Centroid | VSS Capital Partners | Gridiron Capital | Acquisition | Financial adviser to Centroid (target) | Completed | – | IT Services+1 | Willkie Farr & Gallagher (sell-side) | Gridiron Capital acquisition of Centroid |
| Jul 2026 | Ultra Maritime | Cobham Ultra | Lockheed Martin | Acquisition | Financial adviser to Ultra Maritime (target) | Announced | 3,450.0 | Defence & Aerospace | Weil, Gotshal & Manges (sell-side)Citi (buy-side)Hogan Lovells Cadwalader (buy-side)Fried Frank (buy-side) | Lockheed Martin acquisition of Ultra Maritime |
| Jul 2026 | SAM Companies | Peak Rock Capital | New Mountain Capital | Acquisition | Financial adviser to SAM (target) | Announced | – | Infrastructure Services+1 | Kirkland & Ellis (sell-side)Houlihan Lokey (sell-side) | New Mountain Capital acquisition of SAM Companies |
| Jul 2026 | Verne Global UK data centre business | Verne Global | Arcus Infrastructure Partners | Asset sale | Financial adviser to Verne Global (target) | Announced | – | Data Centers | Arcus Infrastructure Partners acquisition of Verne Global UK data centre business | |
| Jul 2026 | EdgeConneX | – | CPPIB | Stake | Financial adviser to CPPIB (acquirer) | Announced | 1,750.0 | Data Centers+1 | CPPIB stake in EdgeConneX | |
| Jul 2026 | MTX652 | Mission Therapeutics | Dimerix | Asset sale | Financial adviser to Mission Therapeutics (seller) | Announced | 292.0 | Biotech+1 | Dimerix acquisition of MTX652 | |
| Jul 2026 | Copia Power | Carlyle | EQT | Asset sale | Financial adviser to Carlyle (seller) | Announced | – | Power & Gas+2 | Latham & Watkins (sell-side) | EQT acquisition of Copia Power |
| Jul 2026 | Perfect Power | – | FIC | Acquisition | Financial adviser to Perfect Power (target) | Announced | – | Industrial Services | FIC acquisition of Perfect Power | |
| Jul 2026 | Prosperity Partners | – | Lightyear Capital | Acquisition | Financial adviser to Prosperity Partners and Unity Partners (target) | Announced | – | Accounting, legal and consulting | Kirkland & Ellis (sell-side)Davis Polk (buy-side) | Lightyear Capital acquisition of Prosperity Partners |
| Jul 2026 | Aligned Data Centers | Macquarie Asset Management | MGX | Acquisition | Financial adviser to sellers represented by Macquarie Asset Management (target) | Completed | 40,000.0 | Data Centers+1 | Skadden, Arps, Slate, Meagher & Flom (buy-side)Latham & Watkins (sell-side)Wells Fargo Securities (sell-side)TD Securities (sell-side)Deutsche Bank (sell-side)Goldman Sachs (sell-side)J.P. Morgan (sell-side)Citizens JMP (sell-side)BofA Securities (sell-side)Kirkland & Ellis (buy-side)Morgan Stanley (buy-side) | MGX acquisition of Aligned Data Centers |
| Jul 2026 | Tabnine | – | Tricentis | Acquisition | Financial adviser to Tabnine (target) | Announced | – | AI+1 | Tricentis acquisition of Tabnine | |
| Jul 2026 | VitalRads | Thrive | Zoetis | Acquisition | Financial adviser to Thrive (seller) | Announced | – | Animal Health+1 | Zoetis acquisition of VitalRads | |
| Jun 2026 | JATT II Acquisition Corp | – | – | Placement | Placement agent to the lead managers | Announced | 225.0 | Biotech+1 | Cantor Fitzgerald (lead manager)LifeSci Capital (lead manager)Davis Polk (lead manager) | JATT II Acquisition Corp placement |
| Jun 2026 | Bio-Techne | – | Merck KGaA | Acquisition | Financial adviser to Merck KGaA (acquirer) | Pending | 11,300.0 | Life Sciences+1 | Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side) | Merck KGaA acquisition of Bio-Techne |
| Jun 2026 | Gentiva | Humana | – | Stake | Financial adviser to Humana (seller) | Announced | 900.0 | Healthcare Services | Debevoise & Plimpton | Stake in Gentiva |
| Jun 2026 | Northern Data AG | – | Rumble | Acquisition | Financial adviser to Rumble (acquirer) | Completed | – | AI Infrastructure+2 | Willkie Farr & Gallagher (buy-side)Latham & Watkins (sell-side)Gleiss Lutz (sell-side)Jefferies (sell-side)Berenberg (sell-side) | Rumble acquisition of Northern Data AG |
| Jun 2026 | Sleep Number business assets | Sleep Number | Sleep Country Canada | Asset sale | Financial adviser to Sleep Number (target) | Completed | 529.5 | Consumer Brands+2 | Davis Polk (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Goodwin (buy-side)PwC (buy-side) | Sleep Country Canada acquisition of Sleep Number business assets |
| Jun 2026 | Sheldahl | Flex | Chase | Acquisition | Financial adviser to Flex (seller) | Completed | – | Specialty Materials+2 | Kirkland & Ellis (buy-side)Fredrikson & Byron (sell-side) | Chase acquisition of Sheldahl |
| Jun 2026 | ERock | – | – | IPO | Bookrunner | Announced | 600.0 | Energy Services+1 | Gibson Dunn (issuer)Morgan Stanley (lead manager)J.P. Morgan (lead manager)Barclays (lead manager)BofA Securities (lead manager)Evercore (lead manager)BNP Paribas (lead manager)Nomura (lead manager)WR Securities (lead manager)Davis Polk (lead manager) | ERock IPO |
| Jun 2026 | Parabilis Medicines | – | – | IPO | Bookrunner | Listed | 670.0 | Biotech+2 | Leerink Partners (lead manager)BofA Securities (lead manager)Evercore (lead manager)LifeSci Capital (lead manager)Goodwin (issuer)Covington & Burling (lead manager) | Parabilis Medicines IPO |
| Jun 2026 | Smith + Howard | – | TPG Growth | Stake | Financial adviser to TPG Growth (acquirer) | Completed | – | Accounting, legal and consulting+1 | Weil, Gotshal & Manges (buy-side)William Blair | TPG Growth stake in Smith + Howard |
| Jun 2026 | Applied Aerospace & Defense | – | – | IPO | Underwriter | Announced | 650.0 | Defence & Aerospace+1 | Morgan Stanley (lead manager)Jefferies (lead manager)BofA Securities (lead manager)RBC Capital Markets (lead manager)Baird (lead manager)Stifel (lead manager)Nomura (lead manager)WR Securities (lead manager)Academy Securities (lead manager)Kirkland & Ellis (issuer)Davis Polk (lead manager) | Applied Aerospace & Defense IPO |
| Jun 2026 | Avenzo Therapeutics | – | – | Placement | Placement agent to the lead managers | Pending | 215.0 | Biotech+2 | Leerink Partners (lead manager)Goldman Sachs (lead manager)Piper Sandler (lead manager)Mintz (lead manager) | Avenzo Therapeutics placement |
| Jun 2026 | Certain assets of TPI Composites | TPI Composites | Energy Capital Partners | Asset sale | Financial adviser to Energy Capital Partners (acquirer) | Announced | – | Renewables+1 | Energy Capital Partners acquisition of Certain assets of TPI Composites | |
| Jun 2026 | Advancing Analytics | – | Lead Edge Capital | Acquisition | Financial adviser to Lead Edge Capital (acquirer) | Announced | – | IT Services+2 | Lead Edge Capital acquisition of Advancing Analytics | |
| May 2026 | SOLV Energy | ASP Endeavor Investco LP | – | Follow-on offering | Bookrunner | Announced | 540.0 | Engineering & Construction+1 | Jefferies (lead manager)J.P. Morgan (lead manager)KeyBanc Capital Markets (lead manager)TD Securities (lead manager)UBS (lead manager)Baird (lead manager)Evercore (lead manager)Nomura (lead manager)WR Securities (lead manager)CIBC Capital Markets (lead manager)Roth Capital Partners (lead manager)Academy Securities (lead manager)Weil, Gotshal & Manges (issuer)Latham & Watkins (lead manager) | SOLV Energy equity raising |
| May 2026 | Newcleo | – | – | Placement | Financial adviser to the issuer | Announced | 220.0 | Nuclear energy+2 | Goldman Sachs (lead manager)Latham & Watkins (lead manager)BTIG (lead manager) | Newcleo placement |
| May 2026 | Newcleo | – | NewHold Investment Corp III | Merger | Financial adviser to newcleo (target) | Completed | 2,500.0 | Nuclear energy+2 | Davis Polk (sell-side)CMS (sell-side)Loeb & Loeb (buy-side)McKinsey & Company (buy-side)Mercer (buy-side)Beckway Group (buy-side)Pillsbury Winthrop Shaw Pittman (buy-side)Marsh McLennan (buy-side)ICR (sell-side) | NewHold Investment Corp III and Newcleo merger |
| May 2026 | Mentari Therapeutics | – | – | Placement | Placement agent to the lead managers | Announced | 290.0 | Biotech+1 | Cooley (lead manager)Gibson Dunn (issuer)Jefferies (lead manager)TD Securities (lead manager)Stifel (lead manager)Wedbush Securities (lead manager) | Mentari Therapeutics placement |
| May 2026 | Noble Environmental | – | Apollo Funds | Acquisition | Financial adviser to Noble Environmental (target) | Completed | – | Environmental Services+1 | Latham & Watkins (buy-side)Sidley Austin (sell-side)Vinson & Elkins (sell-side) | Apollo Funds acquisition of Noble Environmental |
| May 2026 | Rossum | – | Coupa | Acquisition | Financial adviser to Rossum (target) | Completed | – | AI+1 | Kirkland & Ellis (buy-side)Orrick (sell-side) | Coupa acquisition of Rossum |
| May 2026 | Fervo Energy Company | – | – | IPO | Bookrunner | Listed | 1,890.0 | Renewables | J.P. Morgan (lead manager)BofA Securities (lead manager)RBC Capital Markets (lead manager)Barclays (lead manager)Baird (lead manager)BBVA (lead manager)MUFG (lead manager)Societe Generale (lead manager)William Blair (lead manager)Piper Sandler (lead manager)Nomura (lead manager)WR Securities (lead manager)Latham & Watkins (issuer)Vinson & Elkins (lead manager) | Fervo Energy Company IPO |
| May 2026 | Destination XL Group | – | Zodiac Partners II | Acquisition | Financial adviser to Destination XL Group (target) | Rejected | – | Retail+1 | Saratoga Proxy Consulting (buy-side)Greenberg Traurig (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side) | Zodiac Partners II acquisition of Destination XL Group |
| May 2026 | Neogenyx Fuels | – | Ameresco | Joint venture | Financial adviser to Ameresco (acquirer); Financial adviser to Ameresco (target) | Announced | 100.0 | Biofuels+1 | Kirkland & Ellis (buy-side)LazardGibson Dunn | Neogenyx Fuels joint venture |
| May 2026 | BioProtect | – | Olympus | Acquisition | Financial adviser to BioProtect (target) | Announced | 270.0 | Medtech+1 | Olympus acquisition of BioProtect | |
| May 2026 | Markforged's Fused Filament Fabrication (FFF) business | Nano Dimension | Stratasys | Asset sale | Financial adviser to Nano Dimension (seller) | Announced | – | Manufacturing+1 | Stratasys acquisition of Markforged's Fused Filament Fabrication (FFF) business | |
| May 2026 | Reliant Asset Management | – | Sunbelt Rentals | Acquisition | Financial adviser to Reliant Asset Management (target) | Announced | 650.0 | Industrial Services+1 | Sunbelt Rentals acquisition of Reliant Asset Management | |
| Apr 2026 | Avalyn Pharma | – | – | IPO | Underwriter and bookrunner | Listed | 300.0 | Biotech+2 | Morgan Stanley (lead manager)Jefferies (lead manager)Evercore (lead manager)Goodwin (issuer)Davis Polk (lead manager) | Avalyn Pharma IPO |
| Apr 2026 | 50/50 JV integrating Gonetspeed and Greenlight Networks | Oak Hill | T-Mobile | Acquisition | Financial adviser to Oak Hill (seller) | Completed | 2,000.0 | Telecom+1 | Paul, Weiss (sell-side)Lazard (sell-side) | T-Mobile acquisition of 50/50 JV integrating Gonetspeed and Greenlight Networks |
| Apr 2026 | X-Energy | – | – | IPO | Underwriter and bookrunner | Announced | 1,017.9 | Nuclear energy+1 | J.P. Morgan (lead manager)Morgan Stanley (lead manager)Jefferies (lead manager)Moelis & Company (lead manager)Cantor Fitzgerald (lead manager)UBS (lead manager)TD Securities (lead manager)Nomura (lead manager)WR Securities (lead manager)Latham & Watkins (issuer)Skadden, Arps, Slate, Meagher & Flom (lead manager) | X-Energy IPO |
| Apr 2026 | Certara Regulatory and Medical Writing business | Certara | Veristat | Asset sale | Financial adviser to Veristat (acquirer) | Announced | 135.0 | Pharma Services+1 | Perella Weinberg Partners (sell-side)Troutman Pepper Locke (sell-side)McDermott Will & Schulte (buy-side) | Veristat acquisition of Certara Regulatory and Medical Writing business |
| Apr 2026 | Yesway | – | – | IPO | Underwriter and bookrunner | Announced | 280.0 | Retail+1 | Morgan Stanley (lead manager)J.P. Morgan (lead manager)Goldman Sachs (lead manager)Barclays (lead manager)BMO Capital Markets (lead manager)KeyBanc Capital Markets (lead manager)Raymond James (lead manager)Latham & Watkins (issuer)A&O Shearman (lead manager)Morgan Lewis | Yesway IPO |
| Apr 2026 | Arxis | – | – | IPO | Bookrunner | Listed | 1,134.0 | Defence & Aerospace+2 | Nomura (lead manager)WR Securities (lead manager)Davis Polk (issuer)Ropes & Gray (lead manager)Goldman Sachs (lead manager)Morgan Stanley (lead manager)Jefferies (lead manager)Citi (lead manager)RBC Capital Markets (lead manager)Baird (lead manager)Wells Fargo Securities (lead manager)William Blair (lead manager)Rothschild & Co (lead manager)Wolfe | Nomura Alliance (lead manager)Citizens JMP (lead manager) | Arxis IPO |
| Apr 2026 | Madison Air Solutions Corp | – | – | IPO | Bookrunner | Listed | 2,232.7 | Manufacturing | Goldman Sachs (lead manager)Kirkland & Ellis (issuer)Sullivan & Cromwell (lead manager)Barclays (lead manager)Jefferies (lead manager)Wells Fargo Securities (lead manager)William BlairBaird (lead manager) | Madison Air Solutions Corp IPO |
| Apr 2026 | Avanos Medical | – | AIP | Acquisition | Financial adviser to American Industrial Partners (acquirer) | Completed | 1,272.0 | Medtech | Sidley Austin (buy-side)Ropes & Gray (buy-side)Baker Botts (buy-side)J.P. Morgan (sell-side)Alston & Bird (sell-side)UBS (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side) | AIP acquisition of Avanos Medical |
| Apr 2026 | Soleno Therapeutics | – | Neurocrine Biosciences | Acquisition | Financial adviser to Soleno (target); Fairness opinion to Soleno Therapeutics (target) | Completed | 2,900.0 | Biotech+2 | Goldman Sachs (buy-side)Cooley (buy-side)Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)Goodwin (sell-side) | Neurocrine Biosciences acquisition of Soleno Therapeutics |
| Apr 2026 | CallTower | BV Investment Partners | Court Square Capital Management | Acquisition | Financial adviser to Court Square Capital Management (acquirer) | Completed | – | Telecom+2 | Dechert (buy-side) | Court Square Capital Management acquisition of CallTower |
| Apr 2026 | Bridgepointe Technologies | – | Charlesbank Capital Partners | Stake | Financial adviser to Bridgepointe Technologies (target) | Announced | 1,000.0 | IT Services+1 | Kirkland & Ellis (buy-side) | Charlesbank Capital Partners stake in Bridgepointe Technologies |
| Apr 2026 | Inventus Power | – | H.I.G. Capital | Acquisition | Financial adviser to H.I.G. Capital (acquirer) | Announced | – | Manufacturing+1 | H.I.G. Capital acquisition of Inventus Power | |
| Mar 2026 | Geomatikk | – | Axcel | Acquisition | Financial adviser to Geomatikk (target) | Announced | – | Vertical SaaS | Axcel acquisition of Geomatikk | |
| Feb 2026 | atNorth | Partners Group | Canada Pension Plan Investment Board | Acquisition | Financial adviser to Equinix (acquirer) | Completed | 4,000.0 | Data Centers | Slaughter and May (buy-side) | Canada Pension Plan Investment Board acquisition of atNorth |
| Feb 2026 | Generate Biomedicines | – | – | IPO | Underwriter and bookrunner | Listed | 400.0 | Biotech+2 | Goldman Sachs (lead manager)Morgan Stanley (lead manager)Piper Sandler (lead manager)Cantor Fitzgerald (lead manager)Goodwin (issuer)Latham & Watkins (lead manager) | Generate Biomedicines IPO |
| Feb 2026 | Hydraulics International | – | Arcline Investment Management | Acquisition | Financial adviser to Hydraulics International (target) | Announced | – | Defence & Aerospace+2 | RBC Capital Markets (buy-side)Lazard (sell-side) | Arcline Investment Management acquisition of Hydraulics International |
| Feb 2026 | Enhabit | – | Kinderhook Industries | Acquisition | Financial adviser to Kinderhook (acquirer) | Completed | 1,100.0 | Healthcare Services | Goldman Sachs (sell-side)Jones Day (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Kirkland & Ellis (buy-side) | Kinderhook Industries acquisition of Enhabit |
| Feb 2026 | MWI Animal Health | Cencora | Covetrus | Merger | Financial adviser to Cencora (seller) | Pending | 3,500.0 | Animal Health+2 | Goldman Sachs (buy-side)Wells Fargo Securities (buy-side)Deutsche Bank (buy-side)Rabobank (buy-side)Greenhill (buy-side)Natixis (buy-side)Societe Generale (buy-side)TD Securities (buy-side)ING (buy-side)Standard Chartered (buy-side)Debevoise & Plimpton (buy-side)Latham & Watkins (buy-side)Morgan Stanley (sell-side)Freshfields (sell-side) | Covetrus and MWI Animal Health merger |
| Feb 2026 | MaxHealth | Arsenal Capital Partners | CenterWell | Acquisition | Financial adviser to MaxHealth (target) | Completed | – | Healthcare Services | Latham & Watkins (buy-side)Sidley Austin (sell-side)Morgan Stanley (sell-side)J.P. Morgan (buy-side) | CenterWell acquisition of MaxHealth |
| Feb 2026 | Genuine Parts Global Automotive and Global Industrial businesses | Genuine Parts Company | – | Demerger | Financial adviser to Genuine Parts Company (seller) | Announced | – | Automotive+1 | J.P. Morgan (sell-side)King & Spalding (sell-side)Collected Strategies (sell-side) | Genuine Parts Global Automotive and Global Industrial businesses demerger |
| Feb 2026 | Great Lakes Dredge & Dock | – | Saltchuk Resources | Acquisition | Financial adviser to Great Lakes (target); Fairness opinion to Great Lakes Dredge & Dock (target) | Announced | 1,500.0 | Engineering & Construction+1 | Sidley Austin (sell-side)Evercore (buy-side)Fried Frank (buy-side) | Saltchuk Resources acquisition of Great Lakes Dredge & Dock |
| Feb 2026 | European Wax Center | – | General Atlantic | Acquisition | Financial adviser to General Atlantic (acquirer) | Completed | 640.0 | Consumer Services+2 | Moelis & Company (sell-side)Ropes & Gray (sell-side)Edelman Smithfield (sell-side)BofA Securities (buy-side)Paul, Weiss (buy-side) | General Atlantic acquisition of European Wax Center |
| Feb 2026 | SOLV Energy | – | – | IPO | Bookrunner | Listed | 512.5 | Engineering & Construction+2 | Jefferies (lead manager)J.P. Morgan (lead manager)KeyBanc Capital Markets (lead manager)TD Securities (lead manager)UBS (lead manager)Baird (lead manager)Evercore (lead manager)Wolfe | Nomura Alliance (lead manager)CIBC Capital Markets (lead manager)Roth Capital Partners (lead manager)Academy Securities (lead manager)Weil, Gotshal & Manges (issuer)Latham & Watkins (lead manager) | SOLV Energy IPO |
| Feb 2026 | Clear Channel Outdoor Holdings | – | Mubadala Capital | Acquisition | Financial adviser to Mubadala Capital (acquirer) | Announced | 6,200.0 | Advertising and marketing+1 | Morgan Stanley (sell-side)Moelis & Company (sell-side)Kirkland & Ellis (sell-side)J.P. Morgan (buy-side)Freshfields (buy-side)Paul, Weiss (sell-side)Davis Polk (buy-side) | Mubadala Capital acquisition of Clear Channel Outdoor Holdings |
| Feb 2026 | Columbus McKinnon | – | – | Placement | Financial adviser to CD&R | Completed | 800.0 | Manufacturing | Debevoise & Plimpton | Columbus McKinnon placement |
| Feb 2026 | Elara Caring | – | Ares Management | Stake | Financial adviser to Ares Management and DaVita (acquirer) | Announced | – | Healthcare Services+1 | Debevoise & Plimpton (sell-side)Evercore (sell-side) | Ares Management stake in Elara Caring |
| Feb 2026 | TechPro Power Group | Crescentia Capital | IPS | Acquisition | Financial adviser to TechPro Power Group (target) | Completed | – | Testing & Inspection+2 | Willkie Farr & Gallagher (sell-side) | IPS acquisition of TechPro Power Group |
| Feb 2026 | Verinext | – | Arctiq | Acquisition | Financial adviser to Verinext (target) | Announced | – | IT Services+1 | Arctiq acquisition of Verinext | |
| Feb 2026 | Griptape | – | Foundry | Acquisition | Financial adviser to Griptape (target) | Announced | – | AI+1 | Foundry acquisition of Griptape | |
| Feb 2026 | MicroGrid Networks | – | Palisade Infrastructure | Stake | Financial adviser to MicroGrid Networks (target) | Announced | – | Energy Transition+1 | Palisade Infrastructure stake in MicroGrid Networks | |
| Jan 2026 | Common Sense Machines | – | Acquisition | Financial adviser to Common Sense Machines (target) | Announced | – | AI | Gunderson Dettmer (sell-side) | Google acquisition of Common Sense Machines | |
| Jan 2026 | EquipmentShare.com | – | – | IPO | Lead manager and bookrunner | Listed | 747.3 | Industrial Services+2 | Davis Polk (issuer)Latham & Watkins (lead manager)Holland & Knight (issuer)Goldman Sachs (lead manager)Wells Fargo Securities (lead manager)UBS (lead manager)Citi (lead manager)Citizens JMP (lead manager)Truist Securities (lead manager)Baird (lead manager)Oppenheimer & Co. (lead manager)KeyBanc Capital Markets (lead manager)Fifth Third Securities (lead manager)SMBC Nikko Securities (lead manager)M&T Securities (lead manager)Regions Securities (lead manager)BTIG (lead manager)Wedbush Securities (lead manager) | EquipmentShare.com IPO |
| Jan 2026 | Keystone global technology and advisory services practice | RLH Equity | Audax Private Equity | Asset sale | Financial adviser to Keystone (target) | Completed | – | Accounting, legal and consulting+2 | William BlairBaird (buy-side)Goldman Sachs (sell-side) | Audax Private Equity acquisition of Keystone global technology and advisory services practice |
| Jan 2026 | Columbus McKinnon U.S. power chain hoist and chain manufacturing operations | Columbus McKinnon | Pacific Avenue Capital Partners affiliate | Asset sale | Financial adviser to Columbus McKinnon (target) | Pending | 210.0 | Manufacturing | DLA Piper (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Hogan Lovells Cadwalader (sell-side)O'Melveny & Myers (buy-side) | Pacific Avenue Capital Partners affiliate acquisition of Columbus McKinnon U.S. power chain hoist and chain manufacturing operations |
| Jan 2026 | TRG | – | Gemspring Capital | Acquisition | Financial adviser to TRG (target) | Completed | – | IT Services+1 | Kirkland & Ellis (buy-side)Jones Day (sell-side) | Gemspring Capital acquisition of TRG |
| Jan 2026 | Technology Recovery Group (TRG) | – | Gemspring Capital | Acquisition | Financial adviser to Technology Recovery Group (TRG) (target) | Announced | – | IT Services+1 | Gemspring Capital acquisition of Technology Recovery Group (TRG) | |
| Dec 2025 | FBB Holdings I | – | Destination XL Group | Merger | Financial adviser and fairness opinion to Destination XL Group (acquirer) | Announced | 39.8 | Apparel+1 | Greenberg Traurig (buy-side)Rothschild & Co (sell-side)Cleary Gottlieb Steen & Hamilton (sell-side)Joele Frank, Wilkinson Brimmer Katcher (buy-side) | Destination XL Group and FBB Holdings I merger |
| Dec 2025 | Freenome Holdings | – | Perceptive Capital Solutions Corp | Merger | Financial adviser to Freenome (target) | Completed | 725.0 | Diagnostics+2 | Jefferies (buy-side)Leerink Partners (buy-side)TD Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Cooley (buy-side)Greenberg Traurig (sell-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side) | Perceptive Capital Solutions Corp and Freenome Holdings merger |
| Jun 2025 | ProfitSolv | – | FTV Capital, Lightyear Capital | Growth equity | Financial adviser to FTV Capital | Completed | – | Vertical SaaS+1 | Skadden, Arps, Slate, Meagher & FlomWilliam BlairRaymond JamesDavis Polk | ProfitSolv strategic investment |
| Jun 2025 | Felix Pharmaceuticals Pvt | – | Advent International | Stake | Financial adviser to Advent International (acquirer) | Announced | – | Animal Health+2 | Lincoln International (sell-side)A&L Goodbody LLP | Advent International investment in Felix Pharmaceuticals Pvt |
| Feb 2025 | Kito Crosby | KKR-managed funds | Columbus McKinnon | Acquisition | Financial adviser to CD&R | Completed | – | Manufacturing | J.P. Morgan (buy-side)DLA Piper (buy-side)Hodgson Russ (buy-side)Hogan Lovells Cadwalader (buy-side)Skadden, Arps, Slate, Meagher & Flom (buy-side)Evercore (sell-side)Goldman Sachs (sell-side)UBS (sell-side)Kirkland & Ellis (sell-side)Simpson Thacher & Bartlett (sell-side)Debevoise & Plimpton | Columbus McKinnon acquisition of Kito Crosby |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
- Kirkland & Ellis
9 dealsCompare - Goldman Sachs
5 dealsCompare - Latham & Watkins
5 dealsCompare - J.P. Morgan
4 dealsCompare - Evercore
4 dealsCompare - Joele Frank, Wilkinson Brimmer Katcher3 dealsCompare
- Jefferies
2 dealsCompare - Cooley2 dealsCompare
Firms advising the other side of the same deals.
Repeat clients
- CD&R2 deals
- Destination XL Group2 deals
- newcleo2 deals
- SOLV Energy2 deals
Offices and contact
Offices
- New YorkHead office Office page ↗